Research reveals parallels in antidepressant therapies China Daily
FDA Broadens Caplyta Approval to Include Major Depression MedPage Today
Dog and Owner Take Anxiety Medication Together in Viral Video Series TODAY.com
FDA Approves Johnson and Johnson’s Caplyta Pharmaceutical Executive
FDA approves Johnson & Johnson treatment for depressive disorder ROI-NJ
FDA Approves Lumateperone as Adjunct Therapy for Major Depressive Disorder Drug Topics
FDA Approves Lumateperone With Antidepressant Use for Major Depressive Disorder Pharmacy Times
J&J's Caplyta wins FDA nod for depression add-on use FirstWord Pharma
Lumateperone Approved for Major Depression Conexiant
